Larimar Therapeutics, Inc.
LRMRCIK 0001374690 · Every Form 4 filed by insiders at this issuer.
Filings
6
Latest Feb 16, 2024
Unique insiders
15
Showing
6 of 6
Page 1
Top insiders
Most active reporters at Larimar Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| BEN-MAIMON CAROLE | OfficerDirector | 1 |
| Celano Michael | Officer | 1 |
| Clayton Russell | Officer | 1 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Director10% Owner | 1 |
| DEERFIELD PARTNERS, L.P. | Director10% Owner | 1 |
| Deerfield Healthcare Innovations Fund, L.P. | Director10% Owner | 1 |
| Deerfield Mgmt HIF, L.P. | Director10% Owner | 1 |
| Deerfield Mgmt III, L.P. | Director10% Owner | 1 |
| Deerfield Mgmt IV, L.P. | Director10% Owner | 1 |
| Deerfield Mgmt L.P. | Director10% Owner | 1 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Feb 16, 2024 | Flynn James E Director · 10% Owner · Other | P | 1,430,206 | $8.74 | $12,500,000 | |
| Feb 15, 2024 | THOMAS FRANK E Director | P | 2,000 | $11.00 | $22,000 | |
| Jan 19, 2024 | BEN-MAIMON CAROLE President and CEO · Director | A | 66,125 | $0.00 | $0 | |
| Jan 19, 2024 | Clayton Russell Chief Medical Officer | A | 22,500 | $0.00 | $0 | |
| Jan 19, 2024 | Celano Michael Chief Financial Officer | A | 31,250 | $0.00 | $0 | |
| Jan 19, 2024 | Shankar Gopi Chief Development Officer | A | 22,500 | $0.00 | $0 |
Showing 1–6 of 6
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.